Sashendra Senthi

North Bristol NHS Trust — United Kingdom

Medicine · Health Sciences

18h-index4.9kcitations58works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(29), Advanced Radiotherapy Techniques(25), Lung Cancer Treatments and Mutations(13), Management of metastatic bone disease(8), Radiomics and Machine Learning in Medical Imaging(8)

Publications58 total

OUTCOMES OF PERONEAL TENDOSCOPY: THE BRISTOL EXPERIENCE
Orthopaedic Proceedings·2024
ISOLATED ANKLE FUSION FOR FAILED TOTAL ANKLE ARTHROPLASTY USING A SPINE CAGE AND ANTERIOR PLATING CONSTRUCT
Orthopaedic Proceedings·2024
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
BMC Cancer·2024· 1 citedOpen Access
Management and outcomes of glioblastoma: 20‐year experience in a single Australian institution
Journal of Medical Imaging and Radiation Oncology·2023· 3 citedOpen Access
Real‐world data on patterns and outcomes of radiation therapy for brain metastases in a population‐based cohort of lung cancer patients in Victoria
Journal of Medical Imaging and Radiation Oncology·2023· 2 citedOpen Access
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial
International Journal of Radiation Oncology*Biology*Physics·2020· 38 cited
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial
International Journal of Radiation Oncology*Biology*Physics·2020· 8 cited
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
Journal of Clinical Oncology·2020· 1.2k citedOpen Access
Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial
International Journal of Radiation Oncology*Biology*Physics·2020· 21 cited
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
BMC Cancer·2020· 115 citedOpen Access
Stereotactic radiosurgery for managing brain metastases in Victoria, 2012–2017
The Medical Journal of Australia·2020· 9 citedOpen Access
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
2020· 130 citedOpen Access
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial
The Lancet Oncology·2020· 49 cited
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet
International Journal of Radiation Oncology*Biology*Physics·2019· 3 cited
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial
International Journal of Radiation Oncology*Biology*Physics·2019· 58 citedOpen Access
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
BMC Cancer·2019· 250 citedOpen Access
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
The Lancet·2019· 1.8k cited
Identifying optimal clinical scenarios for synchrotron microbeam radiation therapy: A treatment planning study
Physica Medica·2019· 15 cited
Table of Contents
The Journal of the American Dental Association·2019Open Access
Oral health, academic performance, and school absenteeism in children and adolescents
The Journal of the American Dental Association·2018· 123 cited
page 1 of 3Next →

Frequent Co-authors

Suresh Senan(23), David A. Palma(14), Stephen Harrow(12), Alexander V. Louie(12), Devin Schellenberg(12), Robert Olson(11), Cornelis J.A. Haasbeek(11), Stewart Gaede(10), Liam Mulroy(10), Anand Swaminath(10), Ben J. Slotman(10), George Rodrigues(9), Andrew Warner(9), Neil Kopek(8), Michael Lock(7), Brian Yaremko(7), Belal Ahmad(7), Glenn Bauman(7), Mitchell Liu(6), Karen Moore(6)